Evidence map›Paper›PMID 41287016›Full record

ArticleEuropean journal of medical research2025

Efficacy of human-derived fibrin sealant in preventing postoperative adverse events after gastric endoscopic submucosal dissection: a retrospective multicenter study.

Meng Chen, Li Xu, Qin Lu, Yuan Ding, Zhengqing Xue, Hongxia Li, Cuie Cheng, Xilong Ou, Ruihua Shi, Chen Lu

Abstract readMulticenter Study
In one paragraph

Article in European journal of medical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Meng Chen *School of Medicine, Southeast University, Nanjing, 210009, China.
Li Xu *School of Medicine, Southeast University, Nanjing, 210009, China.
Qin LuDepartment of Gastroenterology, Zhongda Hospital Southeast University, Nanjing, 210009, China.
Yuan DingSchool of Medicine, Southeast University, Nanjing, 210009, China.
Zhengqing XueDepartment of Gastroenterology, Yancheng Sixth People's Hospital, Yancheng, 224001, China.
Hongxia LiDepartment of Gastroenterology, the Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, 310009, China.
Cuie ChengDepartment of Gastroenterology, Affiliated Changshu Hospital of Nantong University, Suzhou, 215500, Jiangsu, China.
Xilong OuDepartment of Gastroenterology, Zhongda Hospital Southeast University, Nanjing, 210009, China.
Ruihua ShiDepartment of Gastroenterology, Zhongda Hospital Southeast University, Nanjing, 210009, China.
Chen LuDepartment of Gastroenterology, Zhongda Hospital Southeast University, Nanjing, 210009, China. 13611569073@163.com.

Funding

Administration of Traditional Chinese Medicine of Jiangsu Province,China MS2024139Zhongda Hospital Affiliated with Southeast University, Jiangsu Province High-Level Hospital Construction Funds YKK24268
6 · The paper itself

Abstract

objectivesThe purpose of this study was to evaluate the efficacy of the human-derived fibrin sealant in mitigating adverse events subsequent to endoscopic submucosal dissection (ESD) for the treatment of gastric mucosal lesions.

methodsA retrospective analysis was conducted on data from 661 patients who underwent ESD for gastric mucosal lesions with a resected specimen size ≥ 40 mm. These patients were categorized into the fibrin sealant group and the control group on the basis of postoperative wound management strategies. Comparisons were made between the groups regarding the incidence of adverse events and the postoperative wound healing rate at 1 month. Additionally, factors associated with delayed bleeding following ESD were analyzed.

resultsCompared with the control group, the fibrin sealant group had a significantly lower rate of delayed hemorrhage (1.7% vs. 6.9%; P < 0.001). Subgroup analysis confirmed the consistency of this effect across all the subgroups. Additionally, compared with the control group, the fibrin sealant group had a lower postoperative abdominal pain rate and a lower 24-h postoperative abdominal pain score (P < 0.001). One month after ESD, the fibrin sealant group had a higher wound healing rate (65.4% vs. 51.1%; P = 0.014). Multivariate analysis identified lesions located in the lower one-third of the stomach and specimen size ≥ 60 mm as risk factors for postoperative bleeding.

conclusionThe application of human-derived fibrin sealant to post-ESD wounds effectively decreased the risk of delayed postoperative hemorrhage, mitigated postoperative abdominal pain, and accelerated the healing process of artificial wounds.

Indexed as

Endoscopic Mucosal ResectionFibrin Tissue AdhesivePostoperative ComplicationsStomach NeoplasmsAgedFemaleGastric MucosaHumansMaleMiddle AgedRetrospective StudiesWound HealingFibrin Tissue AdhesiveAdverse eventsEndoscopic mucosal resectionHemorrhageStomach neoplasms

Identifiers

PMID41287016
PMCPMC12642131

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.